Paper41209702
Recent advances in nanoparticles-based sonodynamic and immune checkpoint blockade synergistic therapy for pancreatic ductal adenocarcinoma.
Li H and 5 others. Mater Today Bio, 2025. Cited by 3 papers, by iCite.
Cite this record
ConductScience Library. Recent advances in nanoparticles-based sonodynamic and immune checkpoint blockade synergistic therapy for pancreatic ductal adenocarcinoma. Papers, record 41209702. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41209702
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Recent advances in nanoparticles-based sonodynamic and immune checkpoint blockade synergistic therapy for pancreatic ductal adenocarcinoma.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References205
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 37194682 | Activatable Semiconducting Polymer Pro-nanomodulators for Deep-Tissue Sono-immunotherapy of Orthotopic Pancreatic Cancer. | Angew Chem Int Ed Engl | 2023 | https://conductscience.org/library/papers/37194682 | PubMed |
| 2 | 38994351 | Editorial: Identification of potential therapeutic targets for the tumor microenvironment of gastrointestinal tumor. | Front Immunol | 2024 | https://conductscience.org/library/papers/38994351 | PubMed |
| 3 | 36082582 | Dual-Cascade Responsive Nanoparticles Enhance Pancreatic Cancer Therapy by Eliminating Tumor-Resident Intracellular Bacteria. | Adv Mater | 2022 | https://conductscience.org/library/papers/36082582 | PubMed |
| 4 | 37421765 | Necroptosis inhibits autophagy by regulating the formation of RIP3/p62/Keap1 complex in shikonin-induced ROS dependent cell death of human bladder cancer. | Phytomedicine | 2023 | https://conductscience.org/library/papers/37421765 | PubMed |
| 5 | 34382370 | Low-Intensity Focused Ultrasound-Responsive Ferrite-Encapsulated Nanoparticles for Atherosclerotic Plaque Neovascularization Theranostics. | Adv Sci (Weinh) | 2021 | https://conductscience.org/library/papers/34382370 | PubMed |
| 6 | 36131881 | Sonochemical catalysis as a unique strategy for the fabrication of nano-/micro-structured inorganics. | Nanoscale Adv | 2021 | https://conductscience.org/library/papers/36131881 | PubMed |
| 7 | 37898045 | Ultrasmall iron-doped zinc oxide nanoparticles for ferroptosis assisted sono-chemodynamic cancer therapy. | Colloids Surf B Biointerfaces | 2023 | https://conductscience.org/library/papers/37898045 | PubMed |
| 8 | 32368047 | Therapeutic Effect of Doxorubicin-Chlorin E6-Loaded Mesoporous Silica Nanoparticles Combined with Ultrasound on Triple-Negative Breast Cancer. | Int J Nanomedicine | 2020 | https://conductscience.org/library/papers/32368047 | PubMed |
| 9 | 31639258 | Synergistic N-Heterocyclic Carbene/Palladium-Catalyzed Umpolung 1,4-Addition of Aryl Iodides to Enals. | Angew Chem Int Ed Engl | 2020 | https://conductscience.org/library/papers/31639258 | PubMed |
| 10 | 34948209 | Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma: An Update on Heterogeneity and Therapeutic Targeting. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34948209 | PubMed |
| 11 | 39826335 | A carrier-free ultrasound-responsive polyphenol nanonetworks with enhanced sonodynamic-immunotherapy for synergistic therapy of breast cancer. | Biomaterials | 2025 | https://conductscience.org/library/papers/39826335 | PubMed |
| 12 | 37834228 | Combined or Sequential Treatment with Immune Checkpoint Inhibitors and Car-T Cell Therapies for the Management of Haematological Malignancies: A Systematic Review. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37834228 | PubMed |
| 13 | 39783849 | A Dual-Targeting Biomimetic Nanoplatform Integrates SDT/CDT/Gas Therapy to Boost Synergistic Ferroptosis for Orthotopic Hepatocellular Carcinoma Therapy. | Adv Sci (Weinh) | 2025 | https://conductscience.org/library/papers/39783849 | PubMed |
| 14 | 36539109 | Nanodroplet-enhanced sonodynamic therapy potentiates immune checkpoint blockade for systemic suppression of triple-negative breast cancer. | Acta Biomater | 2023 | https://conductscience.org/library/papers/36539109 | PubMed |
| 15 | 35958563 | The promising immune checkpoint LAG-3 in cancer immunotherapy: from basic research to clinical application. | Front Immunol | 2022 | https://conductscience.org/library/papers/35958563 | PubMed |
| 16 | 33122099 | Sonodynamic therapy-derived multimodal synergistic cancer therapy. | Cancer Lett | 2021 | https://conductscience.org/library/papers/33122099 | PubMed |
| 17 | 38643386 | Dismantlable Coronated Nanoparticles for Coupling the Induction and Perception of Immunogenic Cell Death. | Adv Mater | 2024 | https://conductscience.org/library/papers/38643386 | PubMed |
| 18 | 27141395 | Have lessons from past failures brought us closer to the success of immunotherapy in metastatic pancreatic cancer? | Oncoimmunology | 2016 | https://conductscience.org/library/papers/27141395 | PubMed |
| 19 | 30510367 | Clinical study of ultrasound and microbubbles for enhancing chemotherapeutic sensitivity of malignant tumors in digestive system. | Chin J Cancer Res | 2018 | https://conductscience.org/library/papers/30510367 | PubMed |
| 20 | 30018045 | Dual PD-1 and CTLA-4 Checkpoint Blockade Promotes Antitumor Immune Responses through CD4+Foxp3- Cell-Mediated Modulation of CD103+ Dendritic Cells. | Cancer Immunol Res | 2018 | https://conductscience.org/library/papers/30018045 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42529570 | Endogenous Albumin-Mediated Disassembly of Phthalocyanine Nanoparticles for Tumor-Selective Imaging and Sonodynamic Therapy. | Chem Biomed Imaging | 2026 | https://conductscience.org/library/papers/42529570 | PubMed |
| 42292491 | Stimuli-responsive nanoplatforms for sonodynamic immunotherapy: opportunities and challenges in cancer treatment. | Front Immunol | 2026 | https://conductscience.org/library/papers/42292491 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41209702
GET https://conductscience.org/api/papers/v1/41209702/references?page=2